Clinical trials
Completed Blastic Plasmacytoid Dendritic Cell Neoplasm trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 2 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Chongqing Precision Biotech Co., Ltd | 1 |
| City of Hope Medical Center | 1 |
| Dana-Farber Cancer Institute | 1 |
| M.D. Anderson Cancer Center | 1 |
| Mayo Clinic | 1 |
| National Cancer Institute (NCI) | 1 |
| Samsung Medical Center | 1 |
| Stemline Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 13 |
| Leukemia, Myeloid, Acute | 8 |
| Burkitt Lymphoma | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Blast Crisis | 3 |
| Hematologic Neoplasms | 3 |
| Leukemia | 3 |
| Leukemia, Biphenotypic, Acute | 3 |
| Leukemia, Hairy Cell | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
Trials
Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.